{ "as_of": "2026-11-06", "cmr": "pl-cm-kg/XWAR/PLCLNPH00015", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# CLNPHARMA (GPW Main Market: PLCLNPH00015) — research page\n\nAs of 2026-11-06 · pl-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is CLNPHARMA, listed on GPW Main Market under ticker PLCLNPH00015, with ISIN PLCLNPH00015 and LEI 259400Q0ERJT0NC5DT24. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 31 filings on 24 filing days in the window 2025-11-06 to 2026-11-06, of which 28 are ESPI Current, 2 are ESPI Quarterly and 1 is ESPI half years. The median gap between filing days is 9 days. The latest filing is an ESPI Current dated 2026-10-26, 11 days before the record date of 2026-11-06. The exchange median cadence gap is 8.0 days across 436 issuers, with a median of 31.0 filings and a median latency of 10 days. The sector peer comparison is not on the record for this market.\n\n## Auditor\n\nThe auditor and its location are not on the record. Auditor changes are not on the record, as this market's register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this market's register has no lifecycle type map yet. The halt flag shows listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/pl/mifid-ii-product-governance/r1, with the chapter as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page in the pages read.\n\n## Open research\n\nOne openly published research note is on the record, from Bell Potter Securities dated 2024-06-17.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is not sealed for this market. No issuer years are sealed, no market earliest sealed date is recorded, and the live record began date is not on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.pl-cm-kg.ai/events/XWAR/PLCLNPH00015 (the disclosure lines)\n- https://www.gpw.pl/zawieszenia-i-wykluczenia (the halt flag)\n- https://pl.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://bellpotter.com.au/wp-content/uploads/2024/06/CUV-20240617.pdf (open research)\n- https://mcp.pl-cm-kg.ai/record/XWAR/PLCLNPH00015 (the record)\n", "market": "PL", "node": "pl-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": null, "node_history_from": null, "node_years_sealed": [], "note": "the PL vintage is not sealed; the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false }, "auditor": { "auditor": { "market": "PL", "state": "not_on_record" }, "auditor_firm_id": { "market": "PL", "state": "not_on_record" }, "auditor_location": { "market": "PL", "state": "not_on_record" }, "changes": { "market": "PL", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" } }, "cmr": "pl-cm-kg/XWAR/PLCLNPH00015", "coverage": { "count": 0, "houses": [], "pages_checked": [ { "page": "https://www.kapitales.com.au/assets/reports/KAP1597CUV.pdf", "result": "read: the page does not name the issuer" } ], "read_by": "Perplexity sonar (search) · page read by this rail", "read_date": "2026-11-12", "since": null, "state": "none_found" }, "disclosure": { "against": { "exchange": { "issuers": 436, "median_cadence_gap_days": 8, "median_filings": 31, "median_latency_days": 10, "name": "GPW Main Market" }, "sector": { "market": "PL", "state": "not_on_record" } }, "by_type": { "ESPI Current": 28, "ESPI Quarterly": 2, "ESPI half years": 1 }, "cadence_median_gap_days": 9, "filing_days": 24, "filings": 31, "latency_days": 11, "latest": [ { "category": "ESPI Current", "date": "2026-10-26", "source": "https://www.gpw.pl/espi-ebi-report?geru_id=499375&title=Zakwalifikowanie+projektu+Celon+Pharma+S.A.+do+dofinansowania+w+ramach+Programu+%22Fundusze+Europejskie+dla+Nowoczesnej+Gospodarki%22+-+%C5%9Acie%C5%BCka+SMART", "title": "Zakwalifikowanie projektu Celon Pharma S.A. do dofinansowania w ramach Programu \"Fundusze Europejskie dla Nowoczesnej Gospodarki\" - Ścieżka SMART", "type": "ESPI Current" }, { "category": "ESPI Current", "date": "2026-10-21", "source": "https://www.gpw.pl/espi-ebi-report?geru_id=499198&title=Zakwalifikowanie+do+dofinansowania+dw%C3%B3ch+projekt%C3%B3w+Celon+Pharma+S.A.+w+konkursie+og%C5%82oszonym+przez+Agencj%C4%99+Bada%C5%84+Medycznych+%5BIGEN%5D", "title": "Zakwalifikowanie do dofinansowania dwóch projektów Celon Pharma S.A. w konkursie ogłoszonym przez Agencję Badań Medycznych [IGEN]", "type": "ESPI Current" }, { "category": "ESPI Current", "date": "2026-10-16", "source": "https://www.gpw.pl/espi-ebi-report?geru_id=498969&title=Z%C5%82o%C5%BCenie+wniosk%C3%B3w+o+wydanie+pozwole%C5%84+na+dopuszczenie+do+obrotu+produktu+leczniczego+zawieraj%C4%85cego+semaglutyd+w+postaci+roztworu+do+wstrzykiwa%C5%84+projekt+Reduzek%2C+odpowiednik+leku+Ozempic.", "title": "Złożenie wniosków o wydanie pozwoleń na dopuszczenie do obrotu produktu leczniczego zawierającego semaglutyd w postaci roztworu do wstrzykiwań (projekt Reduzek, odpowiednik leku Ozempic).", "type": "ESPI Current" }, { "category": "ESPI half years", "date": "2026-09-17", "source": "https://www.gpw.pl/espi-ebi-report?geru_id=497148", "title": null, "type": "ESPI half years" }, { "category": "ESPI Current", "date": "2026-09-10", "source": "https://www.gpw.pl/espi-ebi-report?geru_id=496775&title=Uzyskanie+pozytywnej+opinii+Jednostki+Notyfikowanej+Notified+Body+Opinion+dla+wstrzykiwacza+stanowi%C4%85cego+element+rozwoju+produktu+semaglutyd+Celon+Pharma+projekt+Reduzek", "title": "Uzyskanie pozytywnej opinii Jednostki Notyfikowanej (Notified Body Opinion) dla wstrzykiwacza stanowiącego element rozwoju produktu semaglutyd Celon Pharma (projekt Reduzek)", "type": "ESPI Current" } ], "latest_filing_date": "2026-10-26", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.pl-cm-kg.ai/events/XWAR/PLCLNPH00015", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "ESMA FIRDS full equity files 2026-11-07 (registers.esma.europa.eu Solr file index (esma_registers_firds_files)); CFI ES*, MIC in ['XNCO', 'XWAR'], no termination date", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://firds.esma.europa.eu/firds/", "state": "sourced", "value": "GPW Main Market" }, "isin": { "read_by": "ESMA FIRDS full equity files 2026-11-07 (registers.esma.europa.eu Solr file index (esma_registers_firds_files)); CFI ES*, MIC in ['XNCO', 'XWAR'], no termination date", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://firds.esma.europa.eu/firds/", "state": "sourced", "value": "PLCLNPH00015" }, "jurisdiction": { "market": "PL", "state": "not_on_record" }, "lei": { "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN", "read_date": "2026-11-09", "read_date_basis": "the field", "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN PLCLNPH00015)", "state": "sourced", "value": "259400Q0ERJT0NC5DT24" }, "name": { "read_by": "ESMA FIRDS full equity files 2026-11-07 (registers.esma.europa.eu Solr file index (esma_registers_firds_files)); CFI ES*, MIC in ['XNCO', 'XWAR'], no termination date", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://firds.esma.europa.eu/firds/", "state": "sourced", "value": "CLNPHARMA" }, "sector": { "market": "PL", "state": "not_on_record" }, "security_type": { "market": "PL", "state": "not_on_record" }, "segment": { "market": "PL", "state": "not_on_record" }, "ticker": { "read_by": "ESMA FIRDS full equity files 2026-11-07 (registers.esma.europa.eu Solr file index (esma_registers_firds_files)); CFI ES*, MIC in ['XNCO', 'XWAR'], no termination date", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://firds.esma.europa.eu/firds/", "state": "sourced", "value": "PLCLNPH00015" }, "website": { "market": "PL", "state": "not_on_record" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": { "market": "PL", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "domicile_change": { "market": "PL", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "listing": { "market": "PL", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "name_change": { "market": "PL", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "segment_move": { "market": "PL", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" } }, "market": "PL", "node": "pl-cm-kg", "numbers_hash": "sha256:b5ddc0922d65f09093402dcfa6222b758cce9d7a1168d0603740cee1a7d3a3f7", "open_research": { "read_date": "2026-11-12", "rows": [ { "date": "2024-06-17", "kind": "independent", "publisher": "Bell Potter Securities", "read_by": "the note's link answers (200 application/pdf); a document, not read as text", "read_date": "2026-11-12", "source": "https://bellpotter.com.au/wp-content/uploads/2024/06/CUV-20240617.pdf", "state": "sourced", "title": "Clinuvel Pharmaceuticals (CUV) — Looking to Vitiligo" } ], "state": "found" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [], "determinable": false, "read": { "chapter": "https://pl.eu-cm-kg.ai/book/aio.json", "door": "https://pl.eu-cm-kg.ai/mcp", "tool": "get_orderability" }, "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category", "rule_version": "acm-68000/pl/mifid-ii-product-governance/r1", "section": "pl.aio.v5" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.pl-cm-kg.ai/record/XWAR/PLCLNPH00015", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-09", "source": "https://www.gpw.pl/zawieszenia-i-wykluczenia", "value": "listed, not halted" } }, "numbers_hash": "sha256:b5ddc0922d65f09093402dcfa6222b758cce9d7a1168d0603740cee1a7d3a3f7", "path": "/pl/XWAR/PLCLNPH00015", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "The issuer is CLNPHARMA, listed on GPW Main Market under ticker PLCLNPH00015, with ISIN PLCLNPH00015 and LEI 259400Q0ERJT0NC5DT24. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 31 filings on 24 filing days in the window 2025-11-06 to 2026-11-06, of which 28 are ESPI Current, 2 are ESPI Quarterly and 1 is ESPI half years. The median gap between filing days is 9 days. The latest filing is an ESPI Current dated 2026-10-26, 11 days before the record date of 2026-11-06. The exchange median cadence gap is 8.0 days across 436 issuers, with a median of 31.0 filings and a median latency of 10 days. The sector peer comparison is not on the record for this market.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor and its location are not on the record. Auditor changes are not on the record, as this market's register has no lifecycle type map yet.", "title": "Auditor" }, { "id": "events", "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this market's register has no lifecycle type map yet. The halt flag shows listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/pl/mifid-ii-product-governance/r1, with the chapter as of 2026-11-04.", "title": "Orderability" }, { "id": "coverage", "text": "No research houses were found on the issuer's investor-relations page in the pages read.", "title": "Coverage" }, { "id": "open_research", "text": "One openly published research note is on the record, from Bell Potter Securities dated 2024-06-17.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The vintage is not sealed for this market. No issuer years are sealed, no market earliest sealed date is recorded, and the live record began date is not on the record.", "title": "As-of depth" }, { "id": "sources", "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://firds.esma.europa.eu/firds/" }, { "for": "identity.lei", "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download" }, { "for": "the disclosure lines", "source": "https://mcp.pl-cm-kg.ai/events/XWAR/PLCLNPH00015" }, { "for": "the halt flag", "source": "https://www.gpw.pl/zawieszenia-i-wykluczenia" }, { "for": "the orderability chapter", "source": "https://pl.eu-cm-kg.ai/book/aio.json" }, { "for": "open research", "source": "https://bellpotter.com.au/wp-content/uploads/2024/06/CUV-20240617.pdf" }, { "for": "the record", "source": "https://mcp.pl-cm-kg.ai/record/XWAR/PLCLNPH00015" } ], "title": "CLNPHARMA (PLCLNPH00015) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }